T3 Defense Inc. 8-K

What Happened
T3 Defense Inc. (DFNS) announced in an 8-K that on May 5, 2026 it received a written notice from Nasdaq saying the company is not in compliance with the minimum bid-price requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq determined the deficiency based on the company’s closing bid prices from March 23, 2026 through May 4, 2026. The company’s common stock will continue to trade on The Nasdaq Global Market under the symbol “DFNS” while it works to regain compliance.

Key Details

• Notice received: May 5, 2026 (Nasdaq notice of noncompliance with Rule 5550(a)(2)).
• Deficiency period referenced: closing bid prices from March 23, 2026 to May 4, 2026.
• Cure period: 180 calendar days (until November 2, 2026) to achieve a closing bid of at least $1.00 per share for 10 consecutive business days.
• If not cured, the company may apply for a second compliance period (non‑refundable $5,000 application fee) if it meets other Nasdaq Global Market requirements; failure to regain compliance could lead to delisting.
• The company said it will monitor its stock price and may consider options such as a reverse stock split to regain compliance.

Why It Matters
A Nasdaq notice for failure to meet the $1.00 minimum bid requirement is a material compliance issue that can lead to delisting if not cured. Delisting (or even the risk of delisting) can reduce liquidity and make the stock harder to trade on major markets. For now, DFNS remains listed and tradable; investors should watch the company’s closing bid trend, any corporate actions (e.g., reverse stock split) the company may pursue, and further company disclosures about its plan to regain compliance.